Oaktree Acquisition Corp. III Life Sciences (OACC) Operating Expenses (2025 - 2026)

Oaktree Acquisition Corp. III Life Sciences (OACC) reported Operating Expenses of $456538.0 for Q1 2026, up 2.64% on a YoY basis from $444802.0 in Q1 2025, and up 78.69% quarter-over-quarter from $255496.0 in Q4 2025.

Oaktree Acquisition Corp. III Life Sciences (OACC) Operating Expenses (2025 - 2026) Analysis & Trends

Oaktree Acquisition Corp. III Life Sciences has reported Operating Expenses for 2 years, with the latest figure at $456538.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Expenses rose 2.64% year-over-year to $456538.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (changed N/A YoY), and the FY2025 full-year result was $1.2 million, up 239.87% from the prior year.
  • Operating Expenses for Q1 2026 stood at $456538.0, up from $255496.0 in the prior quarter.
  • The five-year high for Operating Expenses was $456538.0 in Q1 2026, with the low at $225579.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn - 427,850.00
2 Berto Acquisition 312.46 Mn 312.46 Mn - 482,100.00
3 Centurion Acquisition 311.65 Mn 311.65 Mn - 201,744.00
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn - 84,204.00
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 1.15 Mn
6 WEN Acquisition 309.15 Mn 309.15 Mn - 225,545.00
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn - 198,194.00
8 Soulpower Acquisition 264.91 Mn 264.91 Mn - 685,558.00
9 BTC Development 262.16 Mn 262.16 Mn - 540,761.00
10 Oaktree Acquisition Corp. III Life Sciences 57.34 Mn 57.34 Mn - 456,538.00

Historic Data

Download Data
DateValue
Mar 31, 2026 456,538.00
Dec 31, 2025 255,496.00
Sep 30, 2025 225,579.00
Jun 30, 2025 269,810.00
Mar 31, 2025 444,802.00